301.694.2999

DONATE

FREDERICK, Md., July 9, 2025 – Frederick Innovative Technology Center, Inc. (FITCI), Frederick’s first and only business incubator, is proud to announce McBee Moore & Vanik IP, LLC ( IP) as its newest Pinnacle-level Power Partner. This partnership highlights MMV IP’s dedication to supporting emerging businesses by providing expert intellectual property (IP) services crucial to protecting … Read more

Creating an end-to-end solution for wafer production FREDERICK, Md., June 4, 2025 /PRNewswire/ — Thin Film Interconnect (TFI), based in Frederick, Maryland, is pleased to announce a strategic technology partnership with Heisler Semiconductor LLC, headquartered in Baltimore, Maryland. This collaboration combines the technical strengths of two Maryland-based innovators to deliver a complete, end-to-end solution for wafer production, Through-Silicon Via (TSV) deposition, … Read more

CarrTech Logo

FREDERICK, Md., April 25, 2025 — Carr Tech Corp, a Maryland-based medical device startup founded by pharmacist-turned-entrepreneur Sue Carr, proudly announces that the company has received FDA 510(k) Class II clearance for its flagship product, FROG (Filter Removal of Glass), an all-in-one filter needle designed to enhance safety and efficiency in medication preparation and administration. “I am humbly grateful … Read more

Frederick Innovative Technology Center, Inc. (FITCI) is proud to announce the appointment of Andres Mendoza as the new Vice Chairman of the FITCI Board of Directors. Andres brings a wealth of experience and an entrepreneurial spirit to this leadership role, further strengthening FITCI’s mission to drive innovation and support the growth of startups in Frederick … Read more

FITCI (Frederick Innovative Technology Center, Inc.) proudly welcomes PRONAV Clinical, an internationally acclaimed early-phase clinical trial supply partner headquartered in Ireland, to its vibrant entrepreneurial ecosystem in partnership with Maryland’s Global Gateway Soft Landing Program. The move marks PRONAV Clinical’s further expansion into the U.S. market, underscoring its commitment to accelerating the supply of innovative … Read more

Cornerstone Genomics, a pioneer in advanced genomic research software, proudly announces the launch of CodeXome, a groundbreaking all-in-one platform designed to accelerate the discovery of genetic targets by providing researchers with extensive cross-species data. Tailored for genome scientists in academia, government, and private enterprise, the cloud-based CodeXome offers a unique opportunity to study gene function … Read more

FITCI Capstone member expands convenience and capability for startup biotech firms. FREDERICK, Md., Aug. 20, 2024 — Mesa Science Associates, Inc. (MSA) and MedSurgPI, LLC announced a partnership between their two companies, which will expand and consolidate the offerings of both to the pharmaceutical and bio-pharmaceutical research and development communities, offering a single source for services of particular importance to … Read more

Press release by TEDCO Maryland-based company seeks to revolutionize green algae growth factors TEDCO, Maryland’s economic engine for technology companies, announced a recent $200,000 Pre-Seed Builder Fund investment in Phycin, Inc. TEDCO’s Pre-Seed Builder Fund is housed under TEDCO’s Social Impact Funds which were created to engage and invest in economically underserved founders and communities. … Read more

“Patrick’s leadership and vision will be instrumental to FITCI as we expand into the next generation of FITCI and continue to drive innovation and support the growth of technology startups in Frederick. Kathie Callahan Brady, President and CEO of FITCI. Frederick Innovative Technology Center, Inc. (FITCI) is proud to announce the appointment of Patrick Wheeler as the … Read more

FREDERICK, Md., May 22, 2024 /PRNewswire/ — Theradaptive, Inc., a regenerative medicine company developing targeted therapeutics, announced today it has been awarded funding from the Maryland Stem Cell Research Fund (MSCRF) to support human clinical trials for its lead product, OsteoAdapt SP.  OsteoAdapt SP is currently in Phase I/II clinical studies for transforaminal lumbar interbody spinal fusion … Read more